Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study
- Conditions
- Healthy subject
- Registration Number
- JPRN-UMIN000029053
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Not provided
1)The candidate is currently undergoing drug or exercise therapy. 2)The candidate currently has, or has a history of, diabetes, liver disease, kidney disease, heart disease, any disease that affects corticosteroid secretion, and/or any other metabolic disease. 3)There are concerns about the potential for the study foods to induce allergic symptoms in the candidate. 4)The candidate is pregnant, or intends to become pregnant or to breastfeed during the study period. 5)The candidate generally or routinely takes any medication that affects body fat and/or lipid metabolism, including over-the-counter drugs, quasi-drugs, and health foods. 6)The candidate is currently dieting with the aim of reducing body weight. 7)The candidate has participated in any other clinical study within the past 1month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal fat area
- Secondary Outcome Measures
Name Time Method Body weight, BMI, body fat percentage